Business Type:Others
Country/Region:China
Ddu Verified
HOT Rank
8/10
T&L Biotechnology
We are professional supplier of Recombinant human IL-7 protein,Recombinant Human IL-15 Protein,Recombinant Human IL-21 Protein,Humanized Anti-Human CD3 mAb,Humanized Anti-Human CD16 mAb,Humanized Anti
Business Type:Others
Country/Region:China
Ddu Verified
HOT Rank
8/10
Catalog Number: GMP-TL107
Product Name | |
Generic Name | OK432 |
Product Information | |
Activity | NK cells activated with this product have a cytotoxic index (T-C) of at least 15% |
Formulation | lyophilized |
Stability & Storage | Samples are stable for up to 24 months from date of receipt at 4 ℃. Recommend to aliquot OK432 into smaller quantities for optimal storage. Avoid repeated freeze-thaw cycles. |
Background | |
OK432 is a freeze-dried devitalized bacterium. OK432-activated neutrophils could kill IFN-γor TNF-α treated cancers cell. OK432 could induce neutrophil-killing effect on autologous tumor cells through CD11b/CD18 and ICAM-1 binding. OK432-induced monocytes are able to kill autologous tumor cells. After stimulation by OK432, lymphocytes shows fine LAK Cell activity and can even fight against anti-NK tumor cells. | |
References | |
1. Sakamoto N1,2, Ishikawa T3,4, Kokura S5,6, Okayama T7,8, Oka K9, Ideno M10, Sakai F11, Kato A12, Tanabe M13, Enoki T14, Mineno J15, Naito Y16, Itoh Y17, Yoshikawa T18. 2. Phase I clinical trial of autologous NK cell therapy using novel expansion method in patients with advanced digestive cancer. J Transl Med. 2015 Aug 25;13:277. doi: 10.1186/s12967-015-0632-8. 3. Pan K1, Lv L2, Zheng HX1, Zhao JJ1, Pan QZ1, Li JJ1, Weng DS1, Wang DD1, Jiang SS1, Chang AE3, Li Q3, Xia JC1. OK-432 synergizes with IFN-γ to confer dendritic cells with enhanced antitumor immunity. Immunol Cell Biol. 2014 Mar;92(3):263-74. doi: 10.1038/icb.2013.87. Epub 2013 Dec 3. 4. Sudo T1, Aruga A, Shimizu K, Matsushita N, Takasaki K. OK432-activated natural killer cells enhanced trastuzumab (Herceptin)-mediated antibody-dependent cellular cytotoxicity in patients with advanced cancer. Anticancer Res. 2006 Nov-Dec;26(6B):4327-33. Trial dosage: A customer can apply for up to five samples a year (the actual trial dosage is determined by telephone or email communication). |